ANGELA DAVIS: Open Payments
NPI 1477119659 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 68 payments from 12 companies in 2025. Trend: 2023 $835 · 2024 $838 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $165 |
| Novartis Pharmaceuticals Corporation | 11 | $159 |
| Merck Sharp & Dohme LLC | 7 | $138 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Amgen Inc. | 5 | $83 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Medtronic, Inc. | 1 | $32 |
Products named: JARDIANCE, LEQVIO, ELIQUIS, VERQUVO, LifeVest, REPATHA, VYNDAQEL, CAMZYOS.
Industry payments across AL — which companies pay providers there.
